HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vanessa Soares Lara Selected Research

Denture Stomatitis

4/2024Anti-Candida activity and biocompatibility of silver nanoparticles associated with denture glaze: a new approach to the management of denture stomatitis.
5/2023Losartan Plays a Fungistatic and Fungicidal Activity Against Candida albicans Biofilms: Drug Repurposing for Localized Candidosis.
1/2023Silver nanoparticles in denture adhesive: An antimicrobial approach against Candida albicans.
11/2022Resilient liner modified by antimicrobials for denture stomatitis treatment: A randomized controlled trial.
3/2021Fibrin Biopolymer Incorporated with Antimicrobial Agents: A Proposal for Coating Denture Bases.
12/2019Candida albicans-Cell Interactions Activate Innate Immune Defense in Human Palate Epithelial Primary Cells via Nitric Oxide (NO) and β-Defensin 2 (hBD-2).
1/2018Antimicrobial activity of denture adhesive associated with Equisetum giganteum- and Punica granatum-enriched fractions against Candida albicans biofilms on acrylic resin surfaces.
5/2017Phagocytosis and nitric oxide production by peritoneal adherent cells in response to Candida albicans in aging: a collaboration to elucidate the pathogenesis of denture stomatitis.
1/2017Intraoral Device for Optimal Antifungal Delivery in a Rat Model.
2/2016Expression of Secreted Aspartyl Proteinases in an Experimental Model of Candida albicans-Associated Denture Stomatitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vanessa Soares Lara Research Topics

Disease

14Denture Stomatitis
04/2024 - 03/2010
5Neoplasms (Cancer)
03/2022 - 01/2012
5Periodontal Diseases (Periodontal Disease)
01/2021 - 06/2008
3Infections
02/2022 - 01/2016
3Alveolar Bone Loss
01/2021 - 01/2019
2Oral Candidiasis (Thrush)
04/2024 - 11/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022 - 07/2018
2Carcinogenesis
03/2022 - 08/2018
2Squamous Cell Carcinoma of Head and Neck
03/2022 - 11/2017
2Neoplasm Metastasis (Metastasis)
03/2022 - 11/2017
2Cysts
01/2021 - 04/2011
2Multiple Sclerosis
11/2020 - 01/2020
2Candidiasis (Moniliasis)
02/2016 - 03/2009
2Granuloma
08/2011 - 01/2004
1Carcinoma (Carcinomatosis)
03/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2020
1Mycoses (Diseases, Fungus)
11/2020
1Diabetes Mellitus
01/2019
1Inflammation (Inflammations)
01/2019
1Oral Leukoplakia
08/2018
1Porcine Reproductive and Respiratory Syndrome (PRRS)
09/2012
1Lobomycosis
08/2011
1Pleomorphic Adenoma
04/2011
1Metaplasia
04/2011
1Chronic Periodontitis
11/2009
1Bone Resorption
06/2008
1Thrombosis (Thrombus)
04/2008
1Leukoplakia
05/2007
1Paracoccidioidomycosis (South American Blastomycosis)
09/2005
1Radicular Cyst
01/2004

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
01/2021 - 11/2009
3Interleukin-10 (Interleukin 10)IBA
07/2018 - 08/2011
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2017 - 09/2005
3Tryptases (Tryptase)IBA
01/2012 - 01/2004
2Keratins (Keratin)IBA
01/2021 - 04/2011
2Ketotifen (Ketotifene)FDA Link
11/2020 - 01/2020
1SilverIBA
04/2024
1Antihypertensive Agents (Antihypertensives)IBA
05/2023
1Therapeutic UsesIBA
01/2023
1Anti-Infective Agents (Microbicides)IBA
11/2022
1Polysaccharides (Glycans)IBA
03/2022
1Interleukin-2 (IL2)IBA
02/2022
1IntegrinsIBA
01/2021
1Nystatin (Mycostatin)FDA LinkGeneric
11/2020
1Immunomodulating AgentsIBA
11/2020
1punicalaginIBA
11/2020
1Type 1 Angiotensin ReceptorIBA
01/2020
1Telmisartan (Micardis)FDA Link
01/2020
1ReninIBA
01/2019
1aliskirenFDA Link
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1Cadherins (E-Cadherin)IBA
08/2018
1Proteins (Proteins, Gene)FDA Link
08/2018
1Interleukin-33IBA
07/2018
1Interleukin-17 (Interleukin 17)IBA
07/2018
1ChemokinesIBA
12/2017
1Drug CarriersIBA
01/2017
1Antifungal AgentsIBA
01/2017
1Aspartic Acid ProteasesIBA
02/2016
1dectin 1IBA
02/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016
1Pattern Recognition ReceptorsIBA
09/2012
1Chymases (Chymase)IBA
01/2012
1Carboxypeptidases A (Carboxypeptidase A)IBA
01/2012
1mast cell protease 4IBA
01/2012
1Peptide Hydrolases (Proteases)FDA Link
01/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2011
1Nitric Oxide Synthase (NO Synthase)IBA
08/2011
1AntigensIBA
11/2009
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2009
1Matrix Metalloproteinases (MMPs)IBA
04/2008

Therapy/Procedure

4Therapeutics
11/2022 - 11/2017
1Complete Denture (Dentures, Complete)
04/2024
1Aftercare (After-Treatment)
03/2022
1Denture Bases
03/2021
1Dental Prosthesis
12/2019
1Dentures
01/2018
1Maxillofacial Prosthesis
07/2010
1Prostheses and Implants (Prosthesis)
03/2010
1Ligation
06/2008